Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Mycobacterial CYP121 as a target for anti-TB drug discovery

Abd El-wahab, H. A. A., Aboraia, A. S., Abdel-Rahman, H. M., El-Gendy, M. A. and Simons, Claire ORCID: https://orcid.org/0000-0002-9487-1100 2016. Mycobacterial CYP121 as a target for anti-TB drug discovery. Der Pharma Chemica 8 (6) , pp. 178-188.

[thumbnail of Mycobacterial CYP121 as a target for anti-TB drug discovery (1).pdf]
Preview
PDF - Published Version
Download (303kB) | Preview

Abstract

Despite the introduction of the first line treatment regimen forty years ago and the continuous trials since that time to introduce new regimens, tuberculosis (TB) is considered to be the cause of considerable mortality worldwide. Recent research highlighted the Mycobacterium tuberculosis (Mtb)CYP450s as potential drug targets. This article reviews mycobacterial CYP121 as a target for anti-TB drug discovery.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Subjects: R Medicine > RM Therapeutics. Pharmacology
ISSN: 0975-413X
Date of First Compliant Deposit: 25 June 2016
Date of Acceptance: 26 April 2016
Last Modified: 05 May 2023 23:32
URI: https://orca.cardiff.ac.uk/id/eprint/92134

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics